Join Us

Health Care Professionals (HCP)

“In science and medicine, information is constantly changing and may become out-of-date as new data becomes available. All articles, videos and interviews were up to date at the time of publication. If you are a patient, this information is not intended to replace advice you may be given by your medical team. If using our Accessibility Tool note that it uses Google Translate which may not always accurately represent the original text.”

This section is designed for Health Care Professionals and covers the latest information available for the treatment and management of SLL and CLL. We aim to keep this area up to date with developments in CLL research.

Latest CLL treatment guidelines

In 2023, the British Society of Haematology published new guidelines for the treatment of SLL/CLL. The full guidelines are available for review here.



The following videos are from three education sessions jointly held between the UKCLL Forum and CLL Support

Please scroll down to view each session:

A CLL refresher with gems from ASH23. The complete evening training course.

Chairs: Prof G Follows and Dr R Walewska

This course is aimed at haematologists in training, associate specialists, specialists’ nurses and any other health care provider.

Session: 22 January 2024

CLL – basic introduction, what’s new in basic biology

How do you break the new diagnosis of CLL? Implications of diagnosis on day-to-day life. Patients’ perspective

Session: 29 January 2024

CLL first-time therapy – what to choose, when and for how long? Big news from ASH

CLL relapsed therapy and the old chestnut of sequencing, are there new data to help the choice?

Session: 5 February 2024

A cardiology masterclass for haematologists

Clinical trials currently available in the UK: commercial and NCRI, FOC access



Videos from the Joint UK CLL Forum and CLL Support two day seminar 1 and 2 July 2023

Some of the comments from participants:

“Really superb speakers, great to feel the combination of evidence nuanced with their own personal practice.”

“All really good talks, Helen Marr in particular was excellent.”

“More than brilliant!”

” I thought it was particularly good, engaging and well chaired”

“Excellent presentations correlating research to clinical practice and recommendations.”

The key talks from this very informative seminar can be viewed here:

Day 1

Chaired by Prof George Follows, Consultant Haematologist, Visiting Professor of Haematology, Anglia Ruskin Medical School, Associate Lecturer, University of Cambridge.

Dr Rosalynd Johnston, Consultant haematologist, University Hospitals Sussex, Royal Sussex County Hospital.

CLL Basic Facts – Dr Rosalynd Johnston and Panel discussion with Dr George Follows; Dr Helen Marr; Dr Piers Patten; and Lelie Duley (patient representative).

Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist, King’s College London. 

Clinical trials in the UK plus Q&A – Dr Piers Patten

Dr Helen Marr

Dr Helen Marr Consultant Haematologist specialising in chronic lymphocytic leukaemia and lymphoma and autologous bone marrow transplant at NHS Newcastle hospitals.

What’s new in CLL – Dr Helen Marr

Day 2

Chaired by Dr R Walewska, Consultant Haematologist, University Hospitals, Dorset

Immunosuppression and risk of infection in CLL – plus Q&A – Dr Helen Parry

Professor Adrian Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Cell Transplantation, The Christie Foundation Trust

Managing autoimmune complications – Prof Adrian Bloor

Dr Nicholas Martinez

Dr Nicholas Martinez – Consultant Haematologist (CLL/lymphoma) at Nottingham University Hospital

Richter’s transformation – Dr Nicholas Martinez


Videos from the July 2022 Joint UK CLL Forum and CLL Support conference

Dr Rosalynd Johnston, Consultant haematologist, University Hospitals Sussex, Royal Sussex County Hospital.
CLL – Natural History; presentation; W & W; Complications related to Not CLL Therapy

Dr Ben Kennedy, Consultant Haematologist and Honorary Associate Professor, Department of Haematology, Leicester Royal Infirmary.
CLL – Laboratory Work-Up and Prognostic Biology

Dr Piers Patten, Clinical Senior Lecturer and Honorary Consultant Haematologist, King’s College London.
CLL First Line Therapy – Choices and Considerations

Dr Helen Marr, Consultant Haematologist, Northern Centre for Cancer Care, Freeman Hospital, Newcastle.
CLL Relapsed Therapy – Choices and considerations

Professor Alan Bloor, Consultant Haematologist and MAHSC Honorary Clinical Chair, University of Manchester, Director of Cell Transplantation, The Christie Foundation Trust
Managing Complications of Standard CLL Treatments

Dr Niamh Appleby, Senior Clinical Researcher in Haematology, Molecular Haematology, John Radcliffe Hospital, Oxford.

CLL and Genomica: A New Standard?